Status:
AVAILABLE
Expanded Access to Triheptanoin
Lead Sponsor:
Ultragenyx Pharmaceutical Inc
Conditions:
Long Chain Fatty Acid Oxidation Disorders
Eligibility:
All Genders
Brief Summary
Expanded access may be provided for qualified patients who have limited treatment options and are not eligible for a clinical trial.
Detailed Description
Long Chain Fatty Acid Oxidation Disorders (LC-FAOD) and other Non-FAOD conditions, where applicable: Expanded access may be available outside of the US in countries prior to approval by the local regu...
Eligibility Criteria
Inclusion
- \- The participant must not be eligible for a UX007 clinical trial
Exclusion
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03773770
Last Update
September 19 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.